Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
NCT06250309 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2026-05-08
Summary
This is a single-center, proof-of-concept pilot study which uses a cross-over design to compare two dietary interventions/treatments: Western Diet (WD) vs Mediterranean (MD) and impact on quality-of-life parameters in AIH. Participants will receive both treatments through two phases and will be divided into two groups.
Conditions
- Autoimmune Hepatitis
Interventions
- DIETARY_SUPPLEMENT
-
Dietary assignment
A total of 48 subjects will be randomized by a computer program into one of two groups: MD or WD. Participation in each dietary arm lasts 8 weeks, with a 6 week washout period in between each arm.
Sponsors & Collaborators
-
Indiana University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-23
- Primary Completion
- 2027-12-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
NCT02050646 ·Status: COMPLETED ·Phase: NA
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
NCT03178630 ·Status: RECRUITING
-
Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis
NCT03711669 ·Status: UNKNOWN
-
UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease
NCT05812612 ·Status: UNKNOWN
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
NCT03175471 ·Status: RECRUITING
-
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
NCT06761209 ·Status: RECRUITING
-
Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndrome
NCT05954325 ·Status: COMPLETED ·Phase: NA
-
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
NCT06078098 ·Status: RECRUITING
-
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414 ·Status: COMPLETED
-
The Role of Immune Semaphorins in NAFLD
NCT04573543 ·Status: COMPLETED
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Autoimmune Hepatitis in Pediatric Patients
NCT04247490 ·Status: COMPLETED
-
Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure
NCT05909319 ·Status: UNKNOWN
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
Agreement and Reliability of Transient Elastography
NCT05686785 ·Status: RECRUITING
-
Canadian Network for Autoimmune Liver Disease
NCT03569826 ·Status: RECRUITING
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
AIH Risk Stratification With Multiparametric MRI
NCT04339621 ·Status: TERMINATED